375 related articles for article (PubMed ID: 23416198)
1. Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain.
Yu X; Vasiljevic S; Mitchell DA; Crispin M; Scanlan CN
J Mol Biol; 2013 Apr; 425(8):1253-8. PubMed ID: 23416198
[TBL] [Abstract][Full Text] [Related]
2. Identification of a receptor required for the anti-inflammatory activity of IVIG.
Anthony RM; Wermeling F; Karlsson MC; Ravetch JV
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19571-8. PubMed ID: 19036920
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
Holla A; Skerra A
Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
[TBL] [Abstract][Full Text] [Related]
4. High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin.
Galustian C; Park CG; Chai W; Kiso M; Bruening SA; Kang YS; Steinman RM; Feizi T
Int Immunol; 2004 Jun; 16(6):853-66. PubMed ID: 15136555
[TBL] [Abstract][Full Text] [Related]
5. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.
van Die I; van Vliet SJ; Nyame AK; Cummings RD; Bank CM; Appelmelk B; Geijtenbeek TB; van Kooyk Y
Glycobiology; 2003 Jun; 13(6):471-8. PubMed ID: 12626400
[TBL] [Abstract][Full Text] [Related]
6. Specificity of DC-SIGN for mannose- and fucose-containing glycans.
van Liempt E; Bank CM; Mehta P; Garciá-Vallejo JJ; Kawar ZS; Geyer R; Alvarez RA; Cummings RD; Kooyk Yv; van Die I
FEBS Lett; 2006 Nov; 580(26):6123-31. PubMed ID: 17055489
[TBL] [Abstract][Full Text] [Related]
7. Binding of DC-SIGN to glycoproteins expressed in glycoengineered Pichia pastoris.
Cukan MC; Hopkins D; Burnina I; Button M; Giaccone E; Houston-Cummings NR; Jiang Y; Li F; Mallem M; Mitchell T; Moore R; Nylen A; Prinz B; Rios S; Sharkey N; Zha D; Hamilton S; Li H; Stadheim TA
J Immunol Methods; 2012 Dec; 386(1-2):34-42. PubMed ID: 22982058
[TBL] [Abstract][Full Text] [Related]
8. DCIR interacts with ligands from both endogenous and pathogenic origin.
Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
[TBL] [Abstract][Full Text] [Related]
9. Human DC-SIGN and CD23 do not interact with human IgG.
Temming AR; Dekkers G; van de Bovenkamp FS; Plomp HR; Bentlage AEH; Szittner Z; Derksen NIL; Wuhrer M; Rispens T; Vidarsson G
Sci Rep; 2019 Jul; 9(1):9995. PubMed ID: 31292524
[TBL] [Abstract][Full Text] [Related]
10. [Glycosylation of antibodies and their pathogenic effect].
Hernández-Pando R; Olivares N
Rev Invest Clin; 2013; 65(6):515-23. PubMed ID: 24687359
[TBL] [Abstract][Full Text] [Related]
11. Frontal affinity chromatography analysis of constructs of DC-SIGN, DC-SIGNR and LSECtin extend evidence for affinity to agalactosylated N-glycans.
Yabe R; Tateno H; Hirabayashi J
FEBS J; 2010 Oct; 277(19):4010-26. PubMed ID: 20840590
[TBL] [Abstract][Full Text] [Related]
12. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.
Anthony RM; Kobayashi T; Wermeling F; Ravetch JV
Nature; 2011 Jun; 475(7354):110-3. PubMed ID: 21685887
[TBL] [Abstract][Full Text] [Related]
13. Semen clusterin is a novel DC-SIGN ligand.
Sabatte J; Faigle W; Ceballos A; Morelle W; Rodríguez Rodrígues C; Remes Lenicov F; Thépaut M; Fieschi F; Malchiodi E; Fernández M; Arenzana-Seisdedos F; Lortat-Jacob H; Michalski JC; Geffner J; Amigorena S
J Immunol; 2011 Nov; 187(10):5299-309. PubMed ID: 22013110
[TBL] [Abstract][Full Text] [Related]
14. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?
Soilleux EJ
Clin Sci (Lond); 2003 Apr; 104(4):437-46. PubMed ID: 12653690
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin.
van Gisbergen KP; Aarnoudse CA; Meijer GA; Geijtenbeek TB; van Kooyk Y
Cancer Res; 2005 Jul; 65(13):5935-44. PubMed ID: 15994972
[TBL] [Abstract][Full Text] [Related]
16. A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs.
Anthony RM; Ravetch JV
J Clin Immunol; 2010 May; 30 Suppl 1():S9-14. PubMed ID: 20480216
[TBL] [Abstract][Full Text] [Related]
17. Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells.
Nonaka M; Ma BY; Murai R; Nakamura N; Baba M; Kawasaki N; Hodohara K; Asano S; Kawasaki T
J Immunol; 2008 Mar; 180(5):3347-56. PubMed ID: 18292560
[TBL] [Abstract][Full Text] [Related]
18. A close look at human IgG sialylation and subclass distribution after lectin fractionation.
Stadlmann J; Weber A; Pabst M; Anderle H; Kunert R; Ehrlich HJ; Peter Schwarz H; Altmann F
Proteomics; 2009 Sep; 9(17):4143-53. PubMed ID: 19688751
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins.
Requena M; Bouhlal H; Nasreddine N; Saidi H; Gody JC; Aubry S; Grésenguet G; Kazatchkine MD; Sekaly RP; Bélec L; Hocini H
Immunology; 2008 Apr; 123(4):508-18. PubMed ID: 17999675
[TBL] [Abstract][Full Text] [Related]
20. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc.
Anumula KR
J Immunol Methods; 2012 Aug; 382(1-2):167-76. PubMed ID: 22683540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
